FIELD: medicine.
SUBSTANCE: invention relates to medicine and can be used to predict risk of intraoperative “no-reflow” syndrome in elective percutaneous coronary intervention in patients with ischemic heart disease. Patient is subjected to pre-operative echocardiography. End-diastolic volume is measured. MB creatine phosphokinase level and fibrinolytic potential are determined in venous blood. Diagnostic results are used in the mathematical model for predicting risk of "no-reflow" syndrome.
EFFECT: method provides increased accuracy of predicting risk of intraoperative "no-reflow" syndrome by evaluating the most significant indicators.
1 cl, 2 dwg, 4 tbl, 2 ex
Authors
Dates
2018-07-03—Published
2017-09-27—Filed